Home » Newsletters » BioWorld

BioWorld

Sep. 13, 1995

View Archived Issues

APPOINTMENTS AND ADVANCEMENTS

NIH COMMITTEE APPROVES NEW COLON CANCER GENE THERAPY FOR HUMAN TRIALS

PROCEPT TO SELL 1.8M SHARES IN PUBLIC OFFERING TO RAISE $11M

OTHER NEWS TO NOTE

ALEXION'S COMPLEMENT-BLOCKING MONOCLONAL RELIEVES RHEUMATOID ARTHRITIS

DEFENSE INDUSTRY PUSHES FOR TAX CUT THAT WOULD PENALIZE BIOTECH FIRMS

TRANSGENIC PIG HEARTS STILL BEATING IN MONKEYS AFTER 60 DAYS

MYRIAD, BAYER STRIKE $71M DEAL

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...
News in brief
BioWorld Asia
BioWorld Asia briefs for Feb. 10, 2026